Daily non-political popular news in brief.

Breast cancer incidence continues to trend low in 2004; decline supports role of HRT

An extended analysis of cancer rates reinforces a strong association between use of hormone replacement therapy and increased breast cancer incidence, according to research led by scientists at the University of Texas M. D. Anderson Cancer Center and published in the April 19 issue of the New England Journal of Medicine.

Read more »

Keywords: breast, cancer, incidence, continues, trend, low, 2004, decline, supports, role, hrt, continue, support

« Previous | Next »

Similar news on "Breast cancer incidence continues to trend low in 2004; decline supports role of HRT":

1. Decline in breast cancer cases likely linked to reduced use of hormone replacement
   12-14-2006 · EurekAlert!
   In 2003, breast cancer incidence in the United States dropped sharply, and this decline may largely be due to the fact that millions of older women stopped using hormone replacement therapy (HRT) in 2002, according to a new analysis led by researchers at the University of Texas M. D. Anderson Cancer Center.
   Similar news · Read more »
   
2. Decrease in breast cancer rates related to reduction in use of hormone replacement therapy
   04-18-2007 · EurekAlert!
   The sharp decline in the rate of new breast cancer cases in 2003 may be related to a national decline in the use of hormone replacement therapy (HRT). Age-adjusted breast cancer incidence rates in women in the United States fell 6.7 percent from 2002 to 2003. Prescriptions for HRT also declined rapidly in 2002 and 2003.
   Similar news · Read more »
   
3. Decrease in breast cancer incidence linked to drop in hormone replacement
   04-18-2007 · EurekAlert!
   A special report in the April 19, 2007, edition of the New England Journal of Medicine concludes that the sharp decline in breast-cancer incidence in 2003, followed by a relative stabilization at a lower rater in 2004, is most likely related to the first report of the Women's Health Initiative and the ensuing drop in hormone-replacement therapy among postmenopausal women.
   Similar news · Read more »
   
4. Drop in breast cancer incidence linked to hormone use, not mammograms
   08-14-2007 · EurekAlert!
   A recent decline in breast cancer incidence is unlikely to be caused by a decrease in mammography screening, according to a study published online Aug. 14 in the Journal of the National Cancer Institute. It is more likely due to the drop in postmenopausal hormone use.
   Similar news · Read more »
   
5. Decrease in breast cancer rates likely reflect HRT reduction and saturation of mammography
   05-03-2007 · EurekAlert!
   A new study, published in the online open access journal Breast Cancer Research, reveals two distinct patterns in the recent breast cancer rates in US women -- a downturn in the incidence rates in almost all age groups above 45 years beginning in 1998-1999, consistent with a levelling off of mammography utilization, and a sharp fall in the rates between 2002 and 2003 in the age groups 50-69 years, likely reflecting the early benefit of the reduced use of HRT.
   Similar news · Read more »
   
6. American Cancer Society report finds breast cancer death rate continues to drop
   09-25-2007 · EurekAlert!
   A report from the American Cancer Society finds the breast cancer death rate in the US continues to drop more than two percent per year, a trend that began in 1990 and is credited to progress in early detection and treatment. But the report says African-American women and women of other racial and ethnic groups have benefited less than white women from the advances that have led to those gains.
   Similar news · Read more »
   
7. Survey underscores importance of emotional/educational needs among women with advanced breast cancer
   12-16-2007 · EurekAlert!
   Psychosocial support in women with advanced or metastatic breast cancer is as important as the need for disease- and treatment-related information, according to results of a survey presented here today at the 30th Annual San Antonio Breast Cancer Symposium.The survey of 367 women with advanced breast cancer, which was conducted by Y-ME National Breast Cancer Organization, also underscores the growing importance of the Internet as an information resource for patients.
   Similar news · Read more »
   
8. Other highlights in the Dec. 6 JNCI
   12-05-2006 · EurekAlert!
   Other highlights in the Dec. 6 JNCI include an Italian model that predicts the risk of breast cancer, a study showing chemotherapy can cause a cognitive decline in some patients, a common genetic variant that is linked to drug-induced diarrhea, a protein that signals poor prognosis in some breast cancer patients and specific genetic changes that are linked to colon cancer in smokers.
   Similar news · Read more »
   
9. New 'knock-out' gene model provides molecular clues to breast cancer
   09-05-2007 · EurekAlert!
   New insights into the role of estrogen receptor in mammary gland development may help scientists better understand the molecular origin of breast cancer, according to new research from the University of Cincinnati.
   Similar news · Read more »
   
10. McGill researchers link enzyme to breast cancer malignancy
    11-29-2007 · EurekAlert!
    McGill University researchers have uncovered the crucial role played by the enzyme focal adhesion kinase in the onset of breast cancer. The research, led by Dr. William Muller -- along with colleagues from McGill and the Beatson Institute for Cancer Research in Scotland -- was published the week of November 26 in the Proceedings of the National Academy of Sciences. The study's first author is Dr. Hicham Lahlou, a post-doctoral fellow in Dr. Muller's lab.
    Similar news · Read more »